Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Behav Brain Res ; 209(1): 93-8, 2010 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-20096733

RESUMO

The objective of the present study is to investigate the effects of single and simultaneous lesions of the noradrenergic and serotonergic pathways (NA-X, 5-HT-X and XX, respectively) by intracerebroventricular administration of selective neurotoxins N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine-HCl (DSP-4) and 5,7-dihydroxytryptamine (5,7-DHT) on anxiety-like behavior in rats. To evaluate the effects of the various lesions, animals were tested in elevated plus-maze (EPM) and light-dark (LD) paradigms. In EPM, single lesions produced strong, statistically significant increase (p<0.001) of both time spent in the open arms (OT) and number of entries into the open arms (OE) compared to sham-lesioned animals. Simultaneous lesion further strengthened this anxiolytic effect causing an approximate 500% elevation of OT compared to sham-lesioned animals. In LD, 5-HT lesion caused a significant (p<0.05) increase in both light movement time and light horizontal activity parameters compared to intact, sham, and NA-lesioned groups. Neither of the lesions caused any change in the spontaneous locomotor activity of the animals up to 15min as measured in activity meter. These findings suggest that single and simultaneous lesions of 5-HT- and NA-pathways modify anxiety-related state of experimental animals to different extents and these modifications alter the behavior of animals differently in the two models used: NA-X and 5-HT-X reduce open space anxiety-like behavior and XX further strengthens this effect in the EPM, while only 5-HT-X is resulting in reduced bright-space anxiety-like behavior leaving the performance of NA-X and XX animals unchanged.


Assuntos
Adaptação Fisiológica/fisiologia , Ansiedade/etiologia , Comportamento Exploratório/fisiologia , Norepinefrina/metabolismo , Serotonina/metabolismo , Comportamento Espacial/fisiologia , 5,7-Di-Hidroxitriptamina/efeitos adversos , 5,7-Di-Hidroxitriptamina/farmacologia , Adaptação Fisiológica/efeitos dos fármacos , Adrenérgicos/efeitos adversos , Adrenérgicos/farmacologia , Inibidores da Captação Adrenérgica/farmacologia , Animais , Benzilaminas/efeitos adversos , Benzilaminas/farmacologia , Cromatografia Líquida de Alta Pressão/métodos , Desipramina/farmacologia , Desipramina/uso terapêutico , Modelos Animais de Doenças , Fluoxetina/farmacologia , Fluoxetina/uso terapêutico , Injeções Intraventriculares/métodos , Masculino , Aprendizagem em Labirinto/efeitos dos fármacos , Atividade Motora/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Serotoninérgicos/efeitos adversos , Serotoninérgicos/farmacologia , Inibidores Seletivos de Recaptação de Serotonina/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...